패널자료를 이용한 제약산업의 연구개발투자 결정요인분석: 외국인투자자와 기관투자가를 중심으로
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이문재 | - |
dc.contributor.author | 최만규 | - |
dc.date.accessioned | 2021-09-04T20:47:02Z | - |
dc.date.available | 2021-09-04T20:47:02Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 2093-5986 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/94908 | - |
dc.description.abstract | Objectives : The aim of this study was to analyze the influence of foreign and institutional investors in the pharmaceutical industry on R&D investments. Methods : The empirical analysis was done for the years 2009 to 2013 which examined the period after the influence of the financial crisis. Financial statements and comments in general and internal transactions were extracted from the TS-2000 of the Korea Listed Company Association. STATA 12.0 was used as the statistical package for the panel analysis. Results : The results show that the shareholding ratio of foreigner investors turned out to have a statistically significant influence on R&D investment. No statistical significance was found in the shareholding ratio of institutional investors. Conclusions : The findings of this study, which indicate that a higher shareholding ratio of foreigner investors leads to greater R&D investment, indicate that foreign investors directly or indirectly impose pressure on a manager to make R&D investments for the long-term. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | 보건의료산업학회 | - |
dc.title | 패널자료를 이용한 제약산업의 연구개발투자 결정요인분석: 외국인투자자와 기관투자가를 중심으로 | - |
dc.title.alternative | Analysis of the Determinants of Research and Development in the Pharmaceutical Industry Using Panel Study Focused Foreign and Institutional Investors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 최만규 | - |
dc.identifier.bibliographicCitation | 보건의료산업학회지, v.9, no.3, pp.247 - 254 | - |
dc.relation.isPartOf | 보건의료산업학회지 | - |
dc.citation.title | 보건의료산업학회지 | - |
dc.citation.volume | 9 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 247 | - |
dc.citation.endPage | 254 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART002036124 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | 제약산업 | - |
dc.subject.keywordAuthor | 연구와 개발 | - |
dc.subject.keywordAuthor | 외국인 투자 | - |
dc.subject.keywordAuthor | 기관투자자 | - |
dc.subject.keywordAuthor | 패널자료 | - |
dc.subject.keywordAuthor | Pharmaceutical Industry | - |
dc.subject.keywordAuthor | Research and Development | - |
dc.subject.keywordAuthor | Foreign Investors | - |
dc.subject.keywordAuthor | Institutional Investors | - |
dc.subject.keywordAuthor | Panel Study | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.